VEGFA and neoplasm: Indeed, given that administration of different agents targeting similar signaling pathways in combination with chemotherapy can result in dissimilar outcomes [33, 34], it is likely that only a specific anti-VEGF/anti-EGFR/chemotherapy combination will be effective against a particular tumor type.